🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#MOGA23 Aboriginal Australians have a 14% higher incidence of cancer… but 45% higher mortality… and the survival rates are getting worse for Aboriginal Australians while improving for others Prof Sandra Thompson Medical Oncology Group of Australia

Great to hear about positive programs that are co-designed, listen to needs of individuals, and take care to communities - we have the potential to eliminate cervical cancer in Australia but only if we include every person with a cervix. Thanks for an amazing session #MOGA23

#MOGA23 better than #ASCO23? Medical Oncology Group of Australia ASCO Bishal Gyawali, MD, PhD, FASCO Matteo Lambertini, MD PhD

We’re working with La Trobe University on a new peer support program for rural patients with rare cancers. Email [email protected] to join our patient focus group.

Interesting poster demonstrating outcomes of targeted treatment in a rare cancer Wei-Sen Lam Australian Rare Cancer (ARC) Portal #MOGA23

Great to hear Bishal Gyawali, MD, PhD, FASCO at #MOGA23 speaking about the (mis)use of language and statistics when cancer publications describe/dilute/misrepresent benefits and risks of new cancer drugs - acceptable, manageable, feasible Common Sense Oncology Dr Deme Karikios

A Senate Inquiry has been initiated focused on ensuring the fair and unbiased availability of diagnosis and medical care for individuals with rare and less common cancer. Support the Inquiry by providing a submission. Submissions close August 31st. loom.ly/VoUH8Hk

A nice article about how to evaluate opportunities, minimise overcommitment, focus on quality, care of self and colleagues. Equally applicable to early career choices in medicine @ausyou

Early start to #COSA2023 with quality and safety of gynae cancer care in QLD Cancer Alliance Queensland Australian Rare Cancer (ARC) Portal COSA

Thought provoking questions from Professor Michael Friedlander at #COSA2023 demonstrating changes in ovarian cancer in the 50 years of COSA - where to next, especially in the challenge of ensuring equity in rare cancers Australian Rare Cancer (ARC) Portal ANZGOG

The ARC Portal is pleased to announce that the ARC Portal PI Professor Clare Scott will be presenting her latest research on molecular therapies for uLMS during a dedicated uLMS research session. uLMS research session: 2 December 2.30pm SGT loom.ly/WNxIm_g

At Gathering Of Kindness last weekend, abetterculture.org.au open for consultation for HCW. Feels like possibility to have a coordinated voice at govt level. We need GPs to be properly funded/ reimbursed for being the backbone of the healthcare system, and to save EDs for emergencies.

Missing out on NZ catchups but still great to able to join #AGITG23 from regional Vic, especially hearing strategies for increased equity and updates on trials we're participating in @ Bendigo Narelle Mcphee @DrSamuelJHarris RTN-Vic Gibbs Lab @rare

Dr Leonard Saltz on the equation for the 'value' of a clinical study. GI Cancer Institute and AGITG #AGITG23

A nice summary thread of updated ESMO CUP guidelines with some changes including how to incorporate further imaging and molecular where available Australian Rare Cancer (ARC) Portal

The responses to the Senate Inquiry into equitable access to diagnosis and treatment for individuals with rare and less common cancers are now available to read on the Parliament of Australia website. Find out more - loom.ly/pwPSB-I

LIVE NOW | Our CEO, Christine Cockburn, is appearing this morning at the Senate Inquiry into equitable access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancer. Read our media release at: bit.ly/3uhfd87

Join or renew your COSA membership before 30 April 2024 to get bonus months of membership and a saving! bit.ly/3hXsDLm